Little Green Pharma has signed a three-year, non-exclusive distribution agreement with Sana Life Sciences that will see the company’s products distributed across the UK and Crown dependencies.
Australian-based Little Green Pharma’s (LGP) branded cannabis oils and flower products will now be available for UK patients. The company has stated that the agreement marks a key plank in its strategy to distribute in the EU and UK.
The products include its 10:10 Classic Oils, Desert Flame flower and a balanced flower product that is currently in development.
Read more: Little Green Pharma wins Italian tender for medical cannabis shipment
The company has stated that under the agreement, minimum purchase orders for flower products will be between 10 and 20 kgs post ramp-up and 500 oil units per shipment. The first purchase order is expected at the end of Q2 or early Q3 and Sana must purchase units valued at between £246,000 and £820,0001 per year to maintain exclusivity for LGP 10:10 Classic Oil.
It has also said that Sana may not purchase any medicinal cannabis oils with the same or similar active ingredient ratios, and that product pricing is fixed with volume discounts.
According to LGP, this development will see more patients in Europe accessing LGP’s products, which is increasing the company’s footprint on the continent. In June 2021, LGP became a major player in Europe’s market with the purchase of its Denmark production operation from Canopy Growth.
Read more: First Denmark cannabis shipment reaches Australia’s Little Green Pharma
In February 2022, the company was recently awarded an Italian Government tender for the shipment of medical cannabis into the country from its Danish cannabis facility after being one of just two to bid for the tender.
[activecampaign form=31]
